APOE and Alzheimer disease: The GAP cohort of healthy elderly with documented AD risk fills the gap of the less frequently studied group of elderly, healthy adults with known APOE‐ε4 genotype, and our study confirms the persistence of these genotype‐driven changes from young adults and elderly healthy stages to early and advanced stages of AD.